| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 3,324,200 | 2,685,400 | 2,658,900 | 2,579,500 | | Cost of Revenue | 2,342,700 | 1,888,800 | 1,867,800 | 1,839,200 | | | Gross Profit | 981,500 | 796,600 | 791,100 | 740,300 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 273,400 | 228,100 | 216,400 | 194,900 | | Non Recurring | 16,400 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 691,700 | 568,500 | 574,700 | 545,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,100) | 29,200 | 5,000 | 14,400 | | Earnings Before Interest And Taxes | 704,700 | 597,700 | 579,700 | 559,800 | | Interest Expense | 24,200 | 10,000 | 13,400 | 11,500 | | Income Before Tax | 680,500 | 587,700 | 566,300 | 548,300 | | Income Tax Expense | 254,900 | 188,100 | 185,300 | 177,800 | | Minority Interest | (3,900) | (2,000) | (4,300) | (4,500) | | | | Net Income From Continuing Ops | 421,700 | 397,600 | 376,700 | 366,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 421,700 | 397,600 | 376,700 | 366,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $421,700 | $397,600 | $376,700 | $366,000 |
|
1.49% Nasdaq 
0.27%
Income Statement
